journal
https://read.qxmd.com/read/36847344/erythema-multiforme-secondary-to-poison-ivy-contact-dermatitis
#1
JOURNAL ARTICLE
Hannah D Smith, Benjamin Williams, Lisa A Beck, Anna De Benedetto
No abstract text is available yet for this article.
February 27, 2023: Dermatitis
https://read.qxmd.com/read/36847309/failure-of-dupilimab-with-severe-prurigo-nodularis-that-responded-well-to-abrocitinib
#2
JOURNAL ARTICLE
Ashley Vander Does, Gil Yosipovitch
No abstract text is available yet for this article.
February 27, 2023: Dermatitis
https://read.qxmd.com/read/36847306/can-you-picture-it-using-smartphone-artificial-intelligence-to-identify-allergenic-plants
#3
JOURNAL ARTICLE
Nicholas Battis, Sara A Hylwa
No abstract text is available yet for this article.
February 27, 2023: Dermatitis
https://read.qxmd.com/read/36800199/safety-of-oral-janus-kinase-inhibitors-in-the-treatment-of-moderate-to-severe-atopic-dermatitis
#4
REVIEW
Shanthi Narla, Jonathan I Silverberg
<u/> Multiple Janus Kinase (JAK) inhibitors were developed as potential treatments for moderate-to-severe atopic dermatitis (AD). There is a substantial amount of safety data from recent trials of oral JAK inhibitors in patients with AD. However, the vast majority of safety data for oral JAK inhibitors is derived from patients with rheumatoid arthritis and other immune-mediated disorders, and is primarily derived from tofacitinib, a pan-selective JAK inhibitor. This narrative review examines safety data for oral JAK inhibitors from studies in AD and other indications...
February 17, 2023: Dermatitis
https://read.qxmd.com/read/36800177/efficacy-of-dupilumab-in-children-6-months-to-11-years-old-with-atopic-dermatitis-a-retrospective-real-world-study-in-china
#5
JOURNAL ARTICLE
Nali Yang, Yahui Ye, Junyi Shao, Hanwen Wu, Qiuyang Xu, Jilin Zhu, Jingjing Liu, Zhiming Li
<u> Background: </u> Atopic dermatitis (AD) is a common skin disease that affects patients' quality of life, especially in the pediatric population. Dupilumab has shown good efficacy and safety in the treatment of AD in adolescents and adults, but the real data on younger children using dupilumab are scarce. <u> Objectives: </u> We investigated the doses, efficacy, and safety of dupilumab in children with moderate-to-severe AD aged ≥6 months to 11 years. <u> Methods: </u> This single-center retrospective cohort analysis included dupilumab-treated patients with severe AD under 12 years of age...
February 17, 2023: Dermatitis
https://read.qxmd.com/read/36796017/facial-contact-urticaria-caused-by-a-moisturizer-containing-1-2-hexanediol
#6
JOURNAL ARTICLE
Hee Jeong Han, Hee Young Kang
No abstract text is available yet for this article.
February 16, 2023: Dermatitis
https://read.qxmd.com/read/36749121/pooled-analysis-of-baricitinib-tolerability-in-patients-with-atopic-dermatitis-in-relation-to-acne-headache-and-gastrointestinal-events-from-8-clinical-trials
#7
JOURNAL ARTICLE
Andreas Wollenberg, Leon Kircik, Eric Simpson, Dennis Brinker, Norito Katoh, Maria Jose Rueda, Maher Issa, Fan Yang, Meghan Feely, Andrew Alexis
<u> Background: </u> Tolerability issues including acne, nausea, and headache have been reported with Janus kinase (JAK) inhibitors for moderate-to-severe atopic dermatitis (AD). <u>Objectives:</u> To report outcomes of tolerability adverse events (AEs) for baricitinib, a JAK1/JAK2 inhibitor, in patients with moderate-to-severe AD. <u>Methods:</u> Acne, headache, and gastrointestinal AEs are reported from placebo-controlled and long-term extensions of pooled data in the baricitinib AD clinical trial program...
February 6, 2023: Dermatitis
https://read.qxmd.com/read/36745387/like-two-little-cowboys-lucky-luke-dermatitis
#8
JOURNAL ARTICLE
Elisa Marzola, Natale Schettini, Alessandro Borghi, Monica Corazza
No abstract text is available yet for this article.
February 6, 2023: Dermatitis
https://read.qxmd.com/read/36735582/piloting-photographic-photonic-patch-testing-pioneering-equitable-diagnosis-of-contact-dermatitis
#9
JOURNAL ARTICLE
Eimear Gilhooley, Lisa Kiely, Catriona Gallagher, Cathal O'Connor, Michael McAuliffe, John Bourke
No abstract text is available yet for this article.
February 3, 2023: Dermatitis
https://read.qxmd.com/read/36730736/clinical-features-and-management-of-stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-a-retrospective-single-center-study
#10
JOURNAL ARTICLE
Yali Li, Yuru Chu, Qunyan Li, Lin Li, Yanan Tuo, Hongmei Wang, Litao Zhang
No abstract text is available yet for this article.
February 2, 2023: Dermatitis
https://read.qxmd.com/read/36730814/chemical-burn-from-benzyl-chloride-with-secondary-eczematization
#11
JOURNAL ARTICLE
Sophie Carrie Shan Cai, Zeenathnisa Mougammadou Aribou, Suzanne Wei Na Cheng, Anthony Teik Jin Goon, Sylvia Tzu Li Teo
No abstract text is available yet for this article.
February 1, 2023: Dermatitis
https://read.qxmd.com/read/36724471/the-association-between-fatigue-and-adult-atopic-dermatitis-a-cross-sectional-study
#12
JOURNAL ARTICLE
Jacob P Thyssen, Lea K Nymand, Julia-Tatjana Maul, Peter Schmid-Grendelmeier, Jashin J Wu, Anne Grete Frøstrup, Susanne Thiesen Gren, Simon Francis Thomsen, Alexander Egeberg
<u> Background: </u> There is currently limited insight into the broader impact of atopic dermatitis (AD) on mental health. Although studies indicate that AD patients may experience fatigue, no study has so far examined fatigue in more granular detail, for example, occurrence of general fatigue, physical fatigue, reduced activity, reduced motivation, and mental fatigue, or correlated fatigue measures with AD severity and symptoms intensity. <u> Objectives: </u> To examine fatigue subtypes and their prevalence in adults with AD, as well as their possible association with AD severity...
February 1, 2023: Dermatitis
https://read.qxmd.com/read/36724458/atopic-dermatitis-and-self-image-design-a-real-life-study-in-children-using-drawings
#13
JOURNAL ARTICLE
Camille Braun, Magali Bourrel-Bouttaz, Olivier Revol, Virginie Verdu, Anaïs Montagnon, Frédéric Bérard, Audrey Nosbaum
<u> Background: </u> Atopic dermatitis (AD) induces alterations of external appearance and self-esteem, with impact on the personal development of the children. However, tools for estimating such suffering are lacking. We aimed to assess how children with AD represent themselves through their drawings. <u> Methods: </u> In this retrospective study, we included children (<18 years) suffering from AD who followed the instruction "draw yourself with and without eczema" at the end of a routine follow-up consultation...
February 1, 2023: Dermatitis
https://read.qxmd.com/read/36719994/the-social-media-self-patch-test-an-analysis-of-recommendations-on-the-r-skincareaddiction-subreddit
#14
JOURNAL ARTICLE
Jennifer Ochanya Ogah, Brandon L Adler
No abstract text is available yet for this article.
January 31, 2023: Dermatitis
https://read.qxmd.com/read/36716204/stevens-johnson-syndrome-toxic-epidermal-necrolysis-overlap-after-the-third-dose-of-bnt162b2-mrna-covid-19-vaccination-and-literature-review
#15
JOURNAL ARTICLE
Mihn-Sook Jue, Hae Chang Joh, Sang Heon Kim, Joo Yeon Ko
No abstract text is available yet for this article.
January 30, 2023: Dermatitis
https://read.qxmd.com/read/36716176/immune-checkpoint-inhibitor-induced-lichen-planus-pemphigoides-report-of-two-cases
#16
JOURNAL ARTICLE
Michael Hagstrom, Gowri Kabbur, Brittney Schultz, Paul Bigliardi, Alessio Giubellino
No abstract text is available yet for this article.
January 30, 2023: Dermatitis
https://read.qxmd.com/read/36917523/teaching-patients-to-teach-themselves-not-by-rote-but-via-repeated-open-application-test
#17
JOURNAL ARTICLE
Malgorzata K Nowakowska, Tiffany Sierro, Ponciano D Cruz
No abstract text is available yet for this article.
January 25, 2023: Dermatitis
https://read.qxmd.com/read/36917528/koebnerization-from-insulin-pump-and-continuous-glucose-monitor-in-a-patient-with-psoriasis
#18
JOURNAL ARTICLE
Caitlyn B Dagenet, Carsten R Hamann, Dathan Hamann
No abstract text is available yet for this article.
January 24, 2023: Dermatitis
https://read.qxmd.com/read/36917519/localized-nummular-dermatitis-of-the-bilateral-breasts-developing-4-months-after-breast-reduction-surgery
#19
JOURNAL ARTICLE
John Miller, William James
No abstract text is available yet for this article.
January 24, 2023: Dermatitis
https://read.qxmd.com/read/36917522/ocular-adverse-events-in-patients-with-atopic-dermatitis-treated-with-upadacitinib-a-real-life-experience
#20
JOURNAL ARTICLE
Federica Gelato, Luca Mastorino, Pietro Quaglino, Giovanni Cavaliere, Michela Ortoncelli, Simone Ribero
<u>Background:</u> Dupilumab, an interleukin (IL)-4 receptor-α inhibitor that blocks IL-4 and IL-13 signaling pathways, is an effective and well-tolerated therapy for moderate-to-severe atopic dermatitis (AD). However, an increased incidence of dupilumab-associated conjunctivitis has been reported in patients treated with dupilumab. In contrast, upadacitinib, a selective Janus kinase 1 inhibitor, is reported to have lower incidence of conjunctivitis than dupilumab. <u>Objective:</u> The aim of this retrospective study was to investigate ocular adverse events in adult patients with moderate-to-severe AD treated with upadacitinib after discontinuing treatment with dupilumab...
January 23, 2023: Dermatitis
journal
journal
40640
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.